- Home
- CGEN vs RCKY Comparison
CGEN vs RCKY Comparison
Compare CGEN & RCKY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGEN
- RCKY
- Stock Information
- Founded
- CGEN 1993
- RCKY 1932
- Country
- CGEN Israel
- RCKY United States
- Employees
- CGEN N/A
- RCKY N/A
- Industry
- CGEN Biotechnology: Biological Products (No Diagnostic Substances)
- RCKY Shoe Manufacturing
- Sector
- CGEN Health Care
- RCKY Consumer Discretionary
- Exchange
- CGEN Nasdaq
- RCKY Nasdaq
- Market Cap
- CGEN 167.4M
- RCKY 155.9M
- IPO Year
- CGEN 2000
- RCKY 1993
- Fundamental
- Price
- CGEN $1.73
- RCKY $22.97
- Analyst Decision
- CGEN
- RCKY Hold
- Analyst Count
- CGEN 0
- RCKY 1
- Target Price
- CGEN N/A
- RCKY $20.00
- AVG Volume (30 Days)
- CGEN 265.3K
- RCKY 46.9K
- Earning Date
- CGEN 08-05-2025
- RCKY 07-29-2025
- Dividend Yield
- CGEN N/A
- RCKY 2.79%
- EPS Growth
- CGEN N/A
- RCKY 2.41
- EPS
- CGEN N/A
- RCKY 1.84
- Revenue
- CGEN $27,589,000.00
- RCKY $454,939,000.00
- Revenue This Year
- CGEN N/A
- RCKY $6.67
- Revenue Next Year
- CGEN $173.80
- RCKY $4.25
- P/E Ratio
- CGEN N/A
- RCKY $12.06
- Revenue Growth
- CGEN N/A
- RCKY N/A
- 52 Week Low
- CGEN $1.13
- RCKY $11.93
- 52 Week High
- CGEN $2.66
- RCKY $37.80
- Technical
- Relative Strength Index (RSI)
- CGEN 57.84
- RCKY 57.65
- Support Level
- CGEN $1.62
- RCKY $20.52
- Resistance Level
- CGEN $1.81
- RCKY $22.62
- Average True Range (ATR)
- CGEN 0.08
- RCKY 0.76
- MACD
- CGEN -0.00
- RCKY -0.10
- Stochastic Oscillator
- CGEN 65.22
- RCKY 70.38
About CGEN Compugen Ltd.
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.
About RCKY Rocky Brands Inc.
Rocky Brands Inc acts as a designer, manufacturer, and marketer of premium-quality footwear and apparel. The company's family of brands includes Rocky, Georgia Boot, Durango, Lehigh, Creative Recreation, and the licensed brand Michelin footwear. The company operates its business through three business segments: Wholesale, Retail and Contract Manufacturing. It generates the majority of the revenue from the Wholesale segment.